Xilio Therapeutics Appoints Yuan Xu, Ph.D., to its Board of Directors
Xilio Therapeutics Announces Initiation of Patient Dosing in Phase 1/2[...]
01/19/2022 | News release | Archived content
Please select the service you want to use:
Smartlinks | Sheldon Whitehouse | United States Senate | News | Crime and Judiciary | Judiciary | Politics and Policy | Government | National Government | Politics | Financial Services | Investment Funds | Investment Services | Judiciary | Arts and Culture | Public Officials
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact